1. Trump Hails Regeneron Deal as First Round of Pharma Pricing Agreements Closes
The Trump administration on Thursday announced completion of a landmark pricing agreement with Regeneron Pharmaceuticals, marking what the White House described as the culmination of its first round of pharmaceutical negotiating deals. The announcement positions the Regeneron accord as the final piece of an initial bat...